<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
 <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
 <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
 <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : People and places : Geographical locations :"/>
 <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
 <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences: Epidemiology : Biology"/>
 <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
 <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
 <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
 <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Infectious Diseases:"/>
 <result pre="Sciences : Infectious Diseases: Vector-Borne Diseases New estimates of the" exact="Zika" post="virus epidemic attack rate in Northeastern Brazil from 2015"/>
 <result pre="A modelling analysis based on Guillain-Barré Syndrome (GBS) surveillance data" exact="Zika" post="versus Guillain-Barré Syndrome http://orcid.org/0000-0003-3253-654XHeDaihaiConceptualizationFormal analysisMethodologyProject administrationSupervisionWriting – review &amp;amp;"/>
 <result pre="Between January 2015 and August 2016, two epidemic waves of" exact="Zika" post="virus (ZIKV) disease swept the Northeastern (NE) region of"/>
 <result pre="Guillain-Barré Syndrome (GBS) were observed concurrently. The mandatory reporting of" exact="ZIKV" post="disease began region-wide in February 2016, and it is"/>
 <result pre="began region-wide in February 2016, and it is believed that" exact="ZIKV" post="cases were significantly under-reported before that. The changing reporting"/>
 <result pre="changing reporting rate has made it difficult to estimate the" exact="ZIKV" post="infection attack rate, and studies in the literature vary"/>
 <result pre="this paper, we aim to estimate the real number of" exact="ZIKV" post="cases (i.e., the infection attack rate) and their dynamics"/>
 <result pre="makes it possible to infer the true epidemic dynamics of" exact="ZIKV" post="cases based on surveillance data of excess GBS cases."/>
 <result pre="excess GBS cases. The model includes the possibility that asymptomatic" exact="ZIKV" post="cases are infectious. The model is fitted to the"/>
 <result pre="reproductive number R 0 , and to infer the true" exact="ZIKV" post="epidemic dynamics. Findings and conclusions The GBS surveillance data"/>
 <result pre="conclusions The GBS surveillance data can be used to study" exact="ZIKV" post="epidemics and may be appropriate when ZIKV reporting rates"/>
 <result pre="used to study ZIKV epidemics and may be appropriate when" exact="ZIKV" post="reporting rates are not well understood. The overall infection"/>
 <result pre="not well understood. The overall infection attack rate (IAR) of" exact="ZIKV" post="is estimated to be 24.1% (95% confidence interval: 17.1%—29.3%)"/>
 <result pre="is likely to be lower than 33% over the two" exact="ZIKV" post="waves. The risk rate from symptomatic ZIKV infection to"/>
 <result pre="over the two ZIKV waves. The risk rate from symptomatic" exact="ZIKV" post="infection to develop GBS was estimated as �? ="/>
 <result pre="Our analysis revealed that asymptomatic infections affect the estimation of" exact="ZIKV" post="epidemics and need to also be carefully considered in"/>
 <result pre="reproduction number and population wide susceptibility, we comment that a" exact="ZIKV" post="outbreak would be unlikely in NE Brazil in the"/>
 <result pre="the near future. Author summary The mandatory reporting of the" exact="Zika" post="virus (ZIKV) disease began region-wide in February 2016, and"/>
 <result pre="began region-wide in February 2016, and it is believed that" exact="ZIKV" post="cases could have been highly under-reported before that. Given"/>
 <result pre="act as a reasonably reliable proxy for inferring the true" exact="ZIKV" post="epidemics. We developed a mathematical model incorporating weather effects"/>
 <result pre="epidemiological parameters. It was found that the attack rate of" exact="ZIKV" post="was likely to be lower than 33% over the"/>
 <result pre="over the two epidemic waves. The risk rate from symptomatic" exact="ZIKV" post="case to develop GBS was estimated to be approximately"/>
 <result pre="The analysis suggests that it would be difficult for another" exact="ZIKV" post="outbreak to appear in Northeastern Brazil in the near"/>
 <result pre="within the manuscript and its Supporting Information files. Introduction The" exact="Zika" post="virus (ZIKV) was first identified in 1947 in the"/>
 <result pre="Zika virus (ZIKV) was first identified in 1947 in the" exact="Zika" post="forest of Uganda [1], and within a few years"/>
 <result pre="the bites of mosquito vectors (usually of the Aedes genus)," exact="ZIKV" post="is an arbovirus from the family Flaviviridae [4, 5]."/>
 <result pre="it infected up to 75% of the island population [11]." exact="ZIKV" post="reached Polynesia in 2013, and at least by 2015,"/>
 <result pre="been associated with severe neurological disorders linked to birth defects." exact="ZIKV" post="infection was found to pass from mother to fetus"/>
 <result pre="abnormalities including possible skull collapse [5]. In addition, since 2014" exact="ZIKV" post="was found to be strongly associated with the Guillain-Barré"/>
 <result pre="[16]. Many studies found a causal link between GBS and" exact="ZIKV" post="disease [17, 18, 19]. In summary, GBS has many"/>
 <result pre="19]. In summary, GBS has many times been associated with" exact="ZIKV" post="outbreaks in many countries [15], making the empirical association"/>
 <result pre="unusually strong. While considered relatively benign for decades since 1947," exact="ZIKV" post="disease suddenly became a major global disease threat. A"/>
 <result pre="true attack rate, the proportion of asymptomatic cases amongst infected" exact="ZIKV" post="cases, the reproductive number. This has led to stepped"/>
 <result pre="associated with the large uncertainties associated with the reporting of" exact="ZIKV" post="cases. Instead, we work with time series of GBS"/>
 <result pre="the doctor. Fig 1 makes clear the strong association between" exact="ZIKV" post="cases and GBS by plotting reported cases of both"/>
 <result pre="GBS data collected during and following the period of a" exact="ZIKV" post="outbreak. We use this to infer the true numbers,"/>
 <result pre="to infer the true numbers, and dynamics in time, of" exact="ZIKV" post="cases. Fig 1 Total ZIKV (top) and GBS (bottom)"/>
 <result pre="and dynamics in time, of ZIKV cases. Fig 1 Total" exact="ZIKV" post="(top) and GBS (bottom) cases as time series summed"/>
 <result pre="in this figure were merely to illustrate the match between" exact="ZIKV" post="and GBS cases data, and the data are not"/>
 <result pre="French Polynesia From October 2013 to April 2014, a severe" exact="ZIKV" post="outbreak hit French Polynesia, and the attack rate (IAR)"/>
 <result pre="delay in the peak timing, and was linked to the" exact="ZIKV" post="outbreak [23]. Based on the IAR of [22], the"/>
 <result pre="[23]. Based on the IAR of [22], the risk of" exact="ZIKV" post="induced GBS can thus be roughly calculated as 0.32"/>
 <result pre="thus be roughly calculated as 0.32 GBS cases per 1,000" exact="ZIKV" post="infections, or just �? = 0.00032. [23] estimated the"/>
 <result pre="These findings are notably different from estimates for a previous" exact="ZIKV" post="outbreak in Yap island in 2007, where the asymptomatic"/>
 <result pre="where the asymptomatic ratio was 4.4:1 and the estimated overall" exact="ZIKV" post="IAR was about 75% [11]. Following the ZIKV outbreak"/>
 <result pre="estimated overall ZIKV IAR was about 75% [11]. Following the" exact="ZIKV" post="outbreak in French Polynesia, the region experienced a Chikungunya"/>
 <result pre="the ZIKV outbreak in French Polynesia, the region experienced a" exact="Chikungunya" post="virus (CHIKV) disease outbreak with an estimated 66,000 cases"/>
 <result pre="and 9 GBS cases occurred [24]. The crude risk of" exact="CHIKV" post="induced GBS was found to be 0.136 per 1,000"/>
 <result pre="CHIKV induced GBS was found to be 0.136 per 1,000" exact="CHIKV" post="infections. Thus, based on these studies [23, 24], a"/>
 <result pre="CHIKV infections. Thus, based on these studies [23, 24], a" exact="ZIKV" post="infection is of (0.32 ÷ 0.136 =) 2.35-fold more"/>
 <result pre="2.35-fold more likely to induce GBS when compared to a" exact="CHIKV" post="infection. Cauchemez et al. (2016) [21] also found that"/>
 <result pre="et al. (2016) [21] also found that the risk of" exact="ZIKV" post="induced microcephaly was 95 cases (34-191) per 10,000 women"/>
 <result pre="were also recorded. Over the two years, two waves of" exact="ZIKV" post="disease were accompanied by two waves of reported GBS"/>
 <result pre="of microcephaly cases with a 23-week delay to the first" exact="ZIKV" post="wave was identified and discussed in [26]. The delay"/>
 <result pre="was identified and discussed in [26]. The delay arises because" exact="ZIKV" post="infections in the first trimester of pregnancy are most"/>
 <result pre="induce microcephaly [21, 27, 28, 29]). Fig 2 The reported" exact="ZIKV" post="cases, excess (or surplus) GBS cases and GBS-to-ZIKV ratio"/>
 <result pre="2015 to November 2016. The red dotted line represents weekly" exact="ZIKV" post="disease cases, the dark blue dotted line represents weekly"/>
 <result pre="cases and the light blue bars are GBS-to-ZIKV ratios. The" exact="CHIKV" post="outbreak of 2016 is denoted with different shades of"/>
 <result pre="for the initial few weeks as the scale of the" exact="ZIKV" post="data is not large enough to compute a meaningful"/>
 <result pre="not large enough to compute a meaningful ratio. A substantial" exact="CHIKV" post="wave was also observed during the second ZIKV wave"/>
 <result pre="A substantial CHIKV wave was also observed during the second" exact="ZIKV" post="wave in 2016 as indicated in Fig 2 and"/>
 <result pre="wave in 2016 as indicated in Fig 2 and [26]." exact="CHIKV" post="can induce GBS with a smaller risk ratio (1"/>
 <result pre="GBS with a smaller risk ratio (1 to 2.35) than" exact="ZIKV" post="as discussed above and according to results in [24,"/>
 <result pre="recent cohort study was conducted on 345 pregnant women with" exact="ZIKV" post="rash observed (presenting at the Oswaldo Cruz Foundation) in"/>
 <result pre="between September 2015 and May 2016 [29]. The IAR of" exact="CHIKV" post="was found to be approximately 17%; and in contrast,"/>
 <result pre="to be approximately 17%; and in contrast, the IAR of" exact="ZIKV" post="was 53%, as based on PCR tests. In addition,"/>
 <result pre="based on PCR tests. In addition, a strong cross-protection between" exact="ZIKV" post="and CHIKV was also observed, but no cross-protection was"/>
 <result pre="PCR tests. In addition, a strong cross-protection between ZIKV and" exact="CHIKV" post="was also observed, but no cross-protection was observed between"/>
 <result pre="CHIKV was also observed, but no cross-protection was observed between" exact="ZIKV" post="and dengue virus (DENV). The IAR of CHIKV was"/>
 <result pre="observed between ZIKV and dengue virus (DENV). The IAR of" exact="CHIKV" post="was 21.1%, and 41.7% for ZIKV-negative women while only"/>
 <result pre="women with rash observed in this period, the ratio of" exact="ZIKV" post="and CHIKV is (roughly) 5 to 2. Evident cross-protection"/>
 <result pre="rash observed in this period, the ratio of ZIKV and" exact="CHIKV" post="is (roughly) 5 to 2. Evident cross-protection between CHIKV"/>
 <result pre="and CHIKV is (roughly) 5 to 2. Evident cross-protection between" exact="CHIKV" post="and ZIKV (but not between DENV and ZIKV) can"/>
 <result pre="is (roughly) 5 to 2. Evident cross-protection between CHIKV and" exact="ZIKV" post="(but not between DENV and ZIKV) can be deduced"/>
 <result pre="2. Evident cross-protection between CHIKV and ZIKV (but not between" exact="DENV" post="and ZIKV) can be deduced from the same study"/>
 <result pre="excess GBS cases in NE Brazil were largely due to" exact="ZIKV" post="disease rather than CHIKV, for two reasons: (i) ZIKV"/>
 <result pre="to ZIKV disease rather than CHIKV, for two reasons: (i)" exact="ZIKV" post="is 2.35-fold likely to induce GBS than CHIKV; and"/>
 <result pre="is 2.35-fold likely to induce GBS than CHIKV; and (ii)" exact="ZIKV" post="IAR could be three times higher than that of"/>
 <result pre="ZIKV IAR could be three times higher than that of" exact="CHIKV" post="based on the Rio de Janeiro study [29] to"/>
 <result pre="is difficult to estimate the infection attack rate (IAR) of" exact="ZIKV" post="directly from the reported ZIKV cases time series given"/>
 <result pre="infection attack rate (IAR) of ZIKV directly from the reported" exact="ZIKV" post="cases time series given the non-constant reporting efforts over"/>
 <result pre="and 2016. In the literature, estimates of the IAR of" exact="ZIKV" post="in Brazil (especially Northeast Region of Brazil) vary from"/>
 <result pre="the S1 Text. Most previous works were based on unreliable" exact="ZIKV" post="surveillance data. In this work, we aim to use"/>
 <result pre="relatively reliable GBS data in NE Brazil to infer the" exact="ZIKV" post="epidemic. The under-reporting of ZIKV cases in 2015 also"/>
 <result pre="NE Brazil to infer the ZIKV epidemic. The under-reporting of" exact="ZIKV" post="cases in 2015 also appears to be reflected in"/>
 <result pre="felt it might not be wise to estimate IAR of" exact="ZIKV" post="directly based on the reported number of microcephaly cases."/>
 <result pre="of time-varying birth rates if using microcephaly cases to infer" exact="ZIKV" post="cases. However, it seems a reasonable approximation to assume"/>
 <result pre="approximation to assume that the number of GBS cases per" exact="ZIKV" post="infected individual should remain constant in time, and that"/>
 <result pre="series. Because of the co-circulation of both dengue fever and" exact="ZIKV" post="during the two waves, misdiagnoses of ZIKV could occur"/>
 <result pre="dengue fever and ZIKV during the two waves, misdiagnoses of" exact="ZIKV" post="could occur [29, 27, 26], especially given both diseases"/>
 <result pre="given both diseases have similar symptoms. Nevertheless, no GBS induced" exact="DENV" post="was reported in the 2015 and 2016 years. Thus,"/>
 <result pre="reported in the 2015 and 2016 years. Thus, the large-scale" exact="ZIKV" post="outbreak was the major source of the excess GBS"/>
 <result pre="excess GBS cases time series to infer the pattern of" exact="ZIKV" post="outbreak and the overall IAR of ZIKV in Northeastern"/>
 <result pre="the pattern of ZIKV outbreak and the overall IAR of" exact="ZIKV" post="in Northeastern Brazil. Mathematical modelling provides a possible way"/>
 <result pre="provides a possible way to infer the epidemic waves of" exact="ZIKV" post="(or together with a minor proportion of CHIKV). First,"/>
 <result pre="CHIKV). First, we assume a constant risk ratio between symptomatic" exact="ZIKV" post="cases and reported GBS cases (ZIKV-GBS ratio), denoted by"/>
 <result pre="cases (ZIKV-GBS ratio), denoted by �?. Second, we simulate our" exact="ZIKV" post="model, and fit the model to observed GBS cases"/>
 <result pre="fit the model to observed GBS cases with a time-dependent" exact="ZIKV" post="transmission rate. Finally, by using iterated filtering techniques, we"/>
 <result pre="time series are plotted in Fig 2 with datasets of" exact="ZIKV" post="and CHIKV for the period. The GBS data used"/>
 <result pre="are plotted in Fig 2 with datasets of ZIKV and" exact="CHIKV" post="for the period. The GBS data used in this"/>
 <result pre="in 2015, which was likely due to the under-reporting of" exact="ZIKV" post="epidemic before 2016 [20]. Daily mean temperature and total"/>
 <result pre="Text. Methods In previous work [6, 40], we developed a" exact="ZIKV" post="transmission model, including both host and vector, based on"/>
 <result pre="mosquito-borne and sexual (human-to-human) transmission of ZIKV. Hosts infected with" exact="ZIKV" post="generate a proportion of GBS cases as determined by"/>
 <result pre="which is the ratio of reported GBS cases to symptomatic" exact="ZIKV" post="cases. In our earlier work, asymptomatic ZIKV cases were"/>
 <result pre="cases to symptomatic ZIKV cases. In our earlier work, asymptomatic" exact="ZIKV" post="cases were assumed to be non-infectious. However, in this"/>
 <result pre="assumed to be non-infectious. However, in this work the asymptomatic" exact="ZIKV" post="cases are now assumed to be infectious, and we"/>
 <result pre="ZIKV-GBS model Fig 3 shows the model diagram of the" exact="ZIKV" post="disease transmission pathways of both humans and the mosquito"/>
 <result pre="[6, 40], we continue to assume that hosts infected with" exact="ZIKV" post="are infectious during the convalescent stage and can infect"/>
 <result pre="host class, Eh is the exposed host class (i.e., within" exact="ZIKV" post="infection latent period), Ah denotes the asymptomatic host class,"/>
 <result pre="susceptible vector class, Ev is the exposed vector (i.e., within" exact="ZIKV" post="infection latent period) and Iv denotes the infectious vector"/>
 <result pre="hosts’ population, and &quot;V�? denotes mosquito vectors’ population. &quot;X→Y�? denotes" exact="ZIKV" post="infected class X infects the (ZIKV) susceptible class Y."/>
 <result pre="4—35 days fixed [49, 50, 51] Ratio: reported GBS symptomatic" exact="ZIKV" post="�? 0.001%—0.1% Nil to be estimated [15, 22, 23]"/>
 <result pre="Markov model) with a &quot;spillover�? rate (�?) from local symptomatic" exact="ZIKV" post="cases. Here �? is the combined effect of the"/>
 <result pre="the GBS reporting ratio and the risk rate of symptomatic" exact="ZIKV" post="inducing GBS i.e., the ratio �? = reported GBS"/>
 <result pre="inducing GBS i.e., the ratio �? = reported GBS symptomatic" exact="ZIKV" post="(see Table 1). The simulated (weekly) number of excess"/>
 <result pre="lagged effect on the local mosquito population, the progress from" exact="ZIKV" post="to GBS development and any reporting delay. Previous studies"/>
 <result pre="at least 3 weeks between the exposure of patients to" exact="ZIKV" post="and the development of GBS (i.e., an incubation period"/>
 <result pre="in the mosquito population, due to the possible interference between" exact="ZIKV" post="and CHIKV for instance, and/or local mosquito control measures."/>
 <result pre="mosquito population, due to the possible interference between ZIKV and" exact="CHIKV" post="for instance, and/or local mosquito control measures. The function"/>
 <result pre="programing language (see S1 Text). Results Connecting the GBS and" exact="ZIKV" post="data, and changing reporting rates Fig 1 plots the"/>
 <result pre="changing reporting rates Fig 1 plots the time series of" exact="ZIKV" post="cases and GBS from the period April 1 of"/>
 <result pre="These time series demonstrate the tight connection between the reported" exact="ZIKV" post="disease and GBS, whose case numbers closely mimic one"/>
 <result pre="The connection is the basis of our method for estimating" exact="ZIKV" post="cases from GBS reports, which as we have discussed,"/>
 <result pre="2. The time series indicate two epidemic outbreaks of reported" exact="ZIKV" post="cases, where the second outbreak in 2016 is far"/>
 <result pre="risk rate of 0.032% i.e., 0.32 GBS cases per 1,000" exact="ZIKV" post="infections (asymptomatic and symptomatic) calculated in [23], the total"/>
 <result pre="(asymptomatic and symptomatic) calculated in [23], the total cases of" exact="ZIKV" post="can be approximated according to the excess GBS cases"/>
 <result pre="2015 there were 233 excess GBS cases and 38,641 reported" exact="ZIKV" post="cases, but in 2016 there were 168 excess GBS"/>
 <result pre="2016 there were 168 excess GBS cases and 70,916 reported" exact="ZIKV" post="cases. The ratio of GBS/Zika reported cases is plotted"/>
 <result pre="by a factor of 0.72 (168/233), the number of reported" exact="ZIKV" post="cases rose by a factor of 70, 916÷38, 641"/>
 <result pre="is that there must have been a major under-reporting of" exact="ZIKV" post="cases in the first year of 2015 [60, 69]."/>
 <result pre="This also seems reasonable since in 2015 the official WHO" exact="ZIKV" post="reporting program had not yet been launched [20]. Suppose"/>
 <result pre="there should have been some 98,353 (= 233 × 70916÷168)" exact="ZIKV" post="reported cases in 2015 rather than only the 38,641"/>
 <result pre="reality. Thus for the 2015 year, it would appear that" exact="ZIKV" post="was under-reported by a factor of 2.5 when compared"/>
 <result pre="under-reported by a factor of 2.5 when compared to the" exact="ZIKV" post="reporting rate in 2016. Fitting the model to GBS"/>
 <result pre="baseline parameters, with several different (possible) values of η (asymptomatic" exact="ZIKV" post="relative infectivity) and θ (proportion of symptomatic ZIKV infections)"/>
 <result pre="η (asymptomatic ZIKV relative infectivity) and θ (proportion of symptomatic" exact="ZIKV" post="infections) considered. The θ = 0.5 simulations correspond to"/>
 <result pre="correspond to a 1:1 ratio of the symptomatic to asymptomatic" exact="ZIKV" post="infection of [22]. Simulations with θ = 0.2 correspond"/>
 <result pre="correspond to the 4:1 ratio of the symptomatic to asymptomatic" exact="ZIKV" post="infection of [11]. Fig 4 The fitting results for"/>
 <result pre="thus our model successfully reconstructed the two waves of the" exact="ZIKV" post="epidemic in NE Brazil. Since we adopted a Negative"/>
 <result pre="and the IAR are summarised in Table 2. For the" exact="ZIKV" post="symptomatic ratio parameter, θ, we follow the previous serological"/>
 <result pre="is sensitive to the change of the symptomatic proportion of" exact="ZIKV" post="infections (θ). Setting θ = 0.2 gives �? ="/>
 <result pre="0.000129 (0.000117,0.000178) 0.2847 (0.2071, 0.3140) To calculate the number of" exact="ZIKV" post="cases and the IAR, we use the estimate obtained"/>
 <result pre="0.00061—ratio of reported GBS to symptomatic ZIKV), and denote the" exact="ZIKV" post="symptomatic ratio as θ, as before. �? can be"/>
 <result pre="can be estimated from the model. Then, the number of" exact="ZIKV" post="cases equals (the number of reported GBS) ÷ [reported"/>
 <result pre="number of the reported GBS/�?/θ. The IAR equals the number" exact="ZIKV" post="cases ÷ the total population in the NE Brazil."/>
 <result pre="can be at least 95% sure the IAR of the" exact="ZIKV" post="epidemic is below 33%, and is likely to be"/>
 <result pre="contribution from the sexual transmission path. The sexual transmissibility of" exact="ZIKV" post="can be ignored owing to (i) the contribution of"/>
 <result pre="and (ii) the recommendation to abstain from sexual contact during" exact="ZIKV" post="epidemics [10]. Hence, the term R h could be"/>
 <result pre="of the whole population were not involved in the 2015-16" exact="ZIKV" post="epidemic. The time points (τ1) when the baseline of"/>
 <result pre="suggested the existence of the non-weather-driven temporal changes in the" exact="ZIKV" post="transmissibility. Results of the sensitivity analysis As is conventional,"/>
 <result pre="the ratio (or risk) of excess GBS cases to symptomatic" exact="ZIKV" post="infections (�?). Fig 5 The Partial Rank Correlation Coefficients"/>
 <result pre="success of de Oliveira et al. (2017) [26] in studying" exact="Zika" post="virus and its impact on human populations including microcephaly"/>
 <result pre="Brazil ([12, 26]. Based on the parallel between cases of" exact="ZIKV" post="disease and cases of GBS (eg., as seen in"/>
 <result pre="(eg., as seen in Fig 1), we have proposed a" exact="ZIKV" post="model that is calibrated on case data of GBS."/>
 <result pre="ZIKV model that is calibrated on case data of GBS." exact="ZIKV" post="case numbers are obtained by scaling up from GBS."/>
 <result pre="trustworthy and reliable compared to numbers obtained through surveillance of" exact="ZIKV" post="where there is much scope for errors in the"/>
 <result pre="reporting rate. Our model considers heterogeneity in symptomatic and asymptomatic" exact="ZIKV" post="infections (i.e., θ and η) as well as the"/>
 <result pre="serological study [22], the ratio �? of GBS to symptomatic" exact="ZIKV" post="cases was found to be 0.00024 and 0.00032 respectively"/>
 <result pre="&quot;was 2.0 (95% CI 0.5-4.5) GBS reported cases per 10,000" exact="ZIKV" post="infections, i.e., 0.02%, (which is) close to the point"/>
 <result pre="the model estimation finds a ratio between GBS and symptomatic" exact="ZIKV" post="cases as �? = 0.000061 or equivalently �? ="/>
 <result pre="95% CI 0.0050%-0.0086%. That is, 1 GBS case per 16,400" exact="ZIKV" post="symptomatic cases which is approximately one quarter or 25%"/>
 <result pre="tentative and based on reasonable first approximations, seems plausible since" exact="ZIKV" post="surveillance was generally unreliable and probably severely under-reported, especially"/>
 <result pre="2016 [60, 69]. For this reason, we avoided using the" exact="ZIKV" post="surveillance data to fit the epidemic model, and our"/>
 <result pre="the indicated range. The model analysis estimated the IAR of" exact="ZIKV" post="cases in NE Brazil to lie between 22% to"/>
 <result pre="with caution. Due to poor surveillance, limited knowledge about the" exact="ZIKV" post="reporting ratio and population seropositivity, the estimates may have"/>
 <result pre="as a whole. Previous estimates of IAR relied on poor" exact="ZIKV" post="data in Brazilian regions: some estimates appear to be"/>
 <result pre="GBS data as a proxy to estimate the IAR of" exact="ZIKV" post="epidemics. We found that the IAR is likely to"/>
 <result pre="rarer disease than microcephaly. Nevertheless, we still chose to predict" exact="ZIKV" post="cases based on GBS rather than microcephaly cases, because"/>
 <result pre="the condition. Return now to the dynamics of the reconstructed" exact="ZIKV" post="cases generated by Eq (1) as calibrated on the"/>
 <result pre="to the intensities reported in Fig 3 of [12] for" exact="ZIKV" post="in Brazil. As the net growth rate of mosquitoes"/>
 <result pre="immediately suggests the existence of non-weather-driven temporal changes in the" exact="ZIKV" post="transmissibility. The baseline drop in m(t) would also lead"/>
 <result pre="0 ( t ) , and indicates a decrease in" exact="ZIKV" post="transmissibility across the two epidemic waves. Since the official"/>
 <result pre="transmissibility across the two epidemic waves. Since the official mandatory" exact="ZIKV" post="reporting began in February 2016, this may have increased"/>
 <result pre="in February 2016, this may have increased public awareness of" exact="ZIKV" post="risk, and thus reduced the spread of infection [70,"/>
 <result pre="time point coincides with the peak timing of the concurrent" exact="CHIKV" post="outbreak [26]. Also, very close to this date, R"/>
 <result pre="rate of ZIKV. We argue that the reporting rate of" exact="ZIKV" post="disease increased dramatically around February and March of 2016,"/>
 <result pre="to assume that the data for the second wave of" exact="ZIKV" post="in 2016 is more reliable than that of the"/>
 <result pre="that of the first. Taking the maximum of the second" exact="ZIKV" post="wave divided by the maximum of the GBS wave,"/>
 <result pre="diseases is 436; i.e., 1 GBS case per 436 reported" exact="ZIKV" post="cases. However, our model fitting finds a ratio between"/>
 <result pre="our model fitting finds a ratio between GBS and symptomatic" exact="ZIKV" post="cases as �? = 0.000061, or 1 GBS case"/>
 <result pre="as �? = 0.000061, or 1 GBS case per 16,400" exact="ZIKV" post="symptomatic cases. Thus, we can conclude that the reporting"/>
 <result pre="Thus, we can conclude that the reporting ratio of symptomatic" exact="ZIKV" post="cases is roughly 16, 400/436 ≈ 38. Namely, for"/>
 <result pre="roughly 16, 400/436 ≈ 38. Namely, for every 38 symptomatic" exact="ZIKV" post="cases, there was 1 case reported, over the second"/>
 <result pre="the population was already exposed to dengue before the 2015" exact="Zika" post="outbreak and this may have provided a significant proportion"/>
 <result pre="titers to dengue virus were associated with reduced risk of" exact="ZIKV" post="infection and symptoms.�? A similar outcome was noted in"/>
 <result pre="al. [83]. Second, Faria et al. [84] indicated that the" exact="Zika" post="virus (Asian ZIKV genotype) may already have been in"/>
 <result pre="Faria et al. [84] indicated that the Zika virus (Asian" exact="ZIKV" post="genotype) may already have been in Brazil as early"/>
 <result pre="[35]. Messina et al. [85] reported that most of the" exact="ZIKV" post="incidences of NE Brazil were distributed in the coastal"/>
 <result pre="here for additional data file. References References 1DickGW, KitchenSF, AJH." exact="Zika" post="virus (I). Isolations and serological specificity. Transactions of the"/>
 <result pre="Annals of Tropical Medicine &amp;amp; Parasitology. 1975;69(1):49–64. 10.1080/00034983.1975.116869831124969 3WikanN, SmithD." exact="Zika" post="virus: history of a newly emerging arbovirus. The Lancet"/>
 <result pre="The Lancet Infectious diseases. 2016;16(7):e119–26. 10.1016/S1473-3099(16)30010-X27282424 4PetersenLR, JamiesonDJ, PowersAM, HoneinM." exact="Zika" post="virus. New England Journal of Medicine. 2016;374(16):1552–63. 10.1056/NEJMra160211327028561 5MlakarJ,"/>
 <result pre="LouY, HeD, PorcoTC, KuangY, ChowellG, et al.Prevention and control of" exact="Zika" post="as a mosquito-borne and sexually transmitted disease: a mathematical"/>
 <result pre="MubayiA, Romero-VivasC. Estimate of the reproduction number of the 2015" exact="Zika" post="virus outbreak in Barranquilla, Colombia, and estimation of the"/>
 <result pre="10.1016/j.epidem.2016.10.00327846442 8AtkinsonB, HearnP, AfroughB, LumleyS, CarterD, AaronsEJ, et al.Detection of" exact="Zika" post="virus in semen. Emerging infectious diseases. 2016;22(5):94010.3201/eid2205.16010727088817 9MussoD, RocheC,"/>
 <result pre="9MussoD, RocheC, RobinE, NhanT, TeissierA, Cao-LormeauV. Potential sexual transmission of" exact="Zika" post="virus. Emerging infectious diseases. 2015;21(2):35910.3201/eid2102.14136325625872 10World Health Organization official"/>
 <result pre="virus. Emerging infectious diseases. 2015;21(2):35910.3201/eid2102.14136325625872 10World Health Organization official website." exact="Zika" post="virus fact sheet.;. Accessed on June 2017. Available from:"/>
 <result pre="12ZhangQ, SunK, ChinazziM, y PionttiA, DeanN, RojasD, et al.Spread of" exact="Zika" post="virus in the Americas. Proceedings of the National Academy"/>
 <result pre="the National Academy of Sciences. 2017;p. 201620161. 13CamposGS, BandeiraAC, SardiS." exact="Zika" post="virus outbreak, Bahia, Brazil. Emerging infectious diseases. 2015;21(10):188510.3201/eid2110.15084726401719 14OehlerE,"/>
 <result pre="DeloreyMJ, SejvarJJ, JohanssonM. Guillain–Barré syndrome risk among individuals infected with" exact="Zika" post="virus: a multi-country assessment. BMC medicine. 2018;16(1):6710.1186/s12916-018-1052-429759069 16The World"/>
 <result pre="WenZ, ChengY, HuangWK, QianX, et al.Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
 <result pre="MarchioriE. &quot;Magnetic resonance imaging findings in Guillain-Barré syndrome caused by" exact="Zika" post="virus infection�?. Neuroradiology. 2016;58(8):837–8. 10.1007/s00234-016-1687-927067205 20The News press entitled"/>
 <result pre="Neuroradiology. 2016;58(8):837–8. 10.1007/s00234-016-1687-927067205 20The News press entitled Exclusive: Brazil says" exact="Zika" post="virus outbreak worse than believed the Reuters.;. Available from:"/>
 <result pre="BompardP, DubT, Guillemette-ArturP, Eyrolle-GuignotD, et al. and others. &quot;Association between" exact="Zika" post="virus and microcephaly in French Polynesia, 2013–15: a retrospective"/>
 <result pre="MonsS, LastereS, RocheC, VanhomwegenJ, et al.Guillain-Barre Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control study. The"/>
 <result pre="SookhareeaC, et al.Increase in cases of Guillain-Barre syndrome during a" exact="Chikungunya" post="outbreak, French Polynesia, 2014 to 2015. Euro Surveill. 2015;20(48):3007910.2807/1560-7917.ES.2015.20.48.3007926690898"/>
 <result pre="theoretical estimate of the risk of microcephaly during pregnancy with" exact="Zika" post="virus infection. Epidemics. 2016;15:66–70. 10.1016/j.epidem.2016.03.00127288540 28EllingtonSR, DevineO, BertolliJ, QuiñonesAM,"/>
 <result pre="Perez-PadillaJ, et al.Estimating the number of pregnant women infected with" exact="Zika" post="virus and expected infants with microcephaly following the Zika"/>
 <result pre="with Zika virus and expected infants with microcephaly following the" exact="Zika" post="virus outbreak in Puerto Rico, 2016. JAMA pediatrics. 2016;170(10):940–5."/>
 <result pre="De MonredonJ, El AmraniM, RogerJC, ServeauxJ. Guillain-Barre syndrome complicating a" exact="Chikungunya" post="virus infection. Neurology. 2007;69(22):2105–7. 10.1212/01.wnl.0000277267.07220.8818040016 32Villamil-GomezW, SilveraLA, Paez-CastellanosJ, Rodriguez-MoralesA."/>
 <result pre="Neurology. 2007;69(22):2105–7. 10.1212/01.wnl.0000277267.07220.8818040016 32Villamil-GomezW, SilveraLA, Paez-CastellanosJ, Rodriguez-MoralesA. Guillain-Barre syndrome after" exact="Chikungunya" post="infection: A case in Colombia. Enfermedades infecciosas y microbiologia"/>
 <result pre="2016;34(2):140–1. 10.1016/j.eimc.2015.05.01226164263 33EconomopoulouA, DominguezM, HelynckB, SissokoD, WichmannO, QuenelP, et al.Atypical" exact="Chikungunya" post="virus infections: clinical manifestations, mortality and risk factors for"/>
 <result pre="Sciences. 2013;280(1770):2013117410.1098/rspb.2013.117424026815 40HeD, GaoD, LouY, ZhaoS, RuanSA. comparison study of" exact="Zika" post="virus outbreaks in French Polynesia, Colombia and the State"/>
 <result pre="Interface. 2010;7:271–83. 10.1098/rsif.2009.015119535416 42GourinatAC, O’ConnorO, CalvezE, GoarantC, Dupont-RouzeyrolM. Detection of" exact="Zika" post="virus in urine. Emerging infectious diseases. 2015;21(1):8410.3201/eid2101.14089425530324 43MussoD, RocheC,"/>
 <result pre="43MussoD, RocheC, RobinE, NhanT, TeissierA, Cao-LormeauV. Potential sexual transmission of" exact="Zika" post="virus. Emerg Infect Dis. 2015;21(2):359–61. 10.3201/eid2102.14136325625872 44ZhaoS, StoneL, GaoD,"/>
 <result pre="all four serotypes. J Infect Dev Ctries. 2009;3:711–22. 10.3855/jidc.61619858573 47BearcroftW." exact="Zika" post="virus infection experimentally induced in a human volunteer. Transactions"/>
 <result pre="simple technique for infection of mosquitoes with viruses transmission of" exact="Zika" post="virus. Transactions of the Royal Society of Tropical Medicine"/>
 <result pre="2016;1(1):79–87. 10.1016/j.idm.2016.08.00129928722 55SasmalSK, GhoshI, HuppertA, ChattopadhyayJ. Modeling the Spread of" exact="Zika" post="Virus in a Stage-Structured Population: Effect of Sexual Transmission."/>
 <result pre="10.1214/08-AOAS201 59KucharskiAJ, FunkS, EggoRM, MalletHP, EdmundsWJ, NillesE. Transmission dynamics of" exact="Zika" post="virus in island populations: a modelling analysis of the"/>
 <result pre="in the variability of the basic reproductive number (R0) for" exact="Zika" post="epidemics in the Pacific islands. Elife. 2016;5:e1987410.7554/eLife.1987427897973 61PaploskiIA, PratesAP,"/>
 <result pre="SilvaMM, WallerLA, et al.Time lags between exanthematous illness attributed to" exact="Zika" post="virus, Guillain-Barré syndrome, and microcephaly, Salvador, Brazil. Emerging infectious"/>
 <result pre="LimaMM, FariaNR, WalkerA, KraemerM, et al.Epidemiological and ecological determinants of" exact="Zika" post="virus transmission in an urban setting. eLife. 2017;6:e29820 Available"/>
 <result pre="2018;451:80–85. 10.1016/j.jtbi.2018.04.04129727633 75CousienA, AbelS, MonthieuxA, AndronicoA, CalmontI, CervantesM, et al.Assessing" exact="Zika" post="Virus Transmission Within Households During an Outbreak in Martinique,"/>
 <result pre="NeryN, CastanhaPM, SacramentoGA, et al.Impact of preexisting dengue immunity on" exact="Zika" post="virus emergence in a dengue endemic region. Science. 2019;363(6427):607–10."/>
 <result pre="BradyOJ, PigottDM, ShearerFM, WeissDJ, et al.Mapping global environmental suitability for" exact="Zika" post="virus. Elife. 2016;5:e1527210.7554/eLife.1527227090089"/>
</results>
